Are you suffering from a cognitive heart problem? Are you so hobbled by chest pain that you are unable to manage the daily activities of life? If the answer is yes, you may want to consider talking to your doctor about the latest heart drug released by Novartis, sold under the brand name of Entresto.
The FDA has approved Entresto for the treatment of heart failure problem. Cognitive heart failure is one of the most common heart issues. This disorder is characterized by the inability of the heart muscle to provide blood to the tissues of the body.
Common causes of heart failure include high blood pressure, congenital heart defects, lung disorders, alcohol/drug abuse and high LDL-cholesterol levels. Patients that suffer from the heart problems experience fatigue and severe shortness of breath.
Novartis’ Entresto drug is one of the latest to hit the market that specifically addresses heart problems. The persecution drug is available to patients whose conditions are categorized as NYHA class II and IV. It contains two active ingredients – Valsartan and Sacubitril – that work differently in reducing the risk of heart failure and repeated hospitalization.
The decision to approve the medication had come after a large clinical trial known as Paradigm-HF that was based on the examination of about 8,400 individuals. The study had found that people suffering from heart diseases that took Entresto were at significantly less risk of dying due to a heart failure.
What’s more, the study had found that people that took the medication were less likely to require repeated hospitalization. About 20 percent or more of patients today require re-hospitalization after 30 days of being hospitalized. So, the drug can greatly help reduce the burden of health care costs for the affected individuals.
According to Dr. Milton Packer, the professor and the chair of the Department of Clinical Sciences at the University of Texas, the highly effective results of the Paradigm-HF clinical trial should persuade the physicians to consider prescribing Entresto to patients instead of the angiotensin receptor blockers or ACE inhibitors.
Final Piece of Advice
The introduction of the drug Entresto represents a significant breakthrough for heart patients. The drug works at a physiological level in reducing the risk of a death due to a heart attack. The medication is considered safe for the majority of the individuals. However, you should not take the medication prior to consulting with a doctor if you suffer from liver or kidney disorders, are pregnant or breastfeed, or take any prescription or OTC medication, herbal or vitamin supplements.
Howard Fensterman would like to see the elimination of health disparities and promoting a healthy living. The charitable donations of Mr. Fensterman have helped in uplifting the lives of thousands of people. He has contributed to numerous charitable organizations that focus on offering affordable medical treatment, as well as finding cures for debilitating diseases.